Teladoc Health (NYSE:TDOC) Price Target Cut to $16.00 by Analysts at Stifel Nicolaus

Teladoc Health (NYSE:TDOC) had its target price trimmed by Stifel Nicolaus from $21.00 to $16.00 in a research note issued to investors on Friday, Benzinga reports. The firm currently has a hold rating on the health services provider’s stock.

TDOC has been the subject of a number of other reports. Piper Sandler reduced their price target on shares of Teladoc Health from $30.00 to $25.00 and set an overweight rating for the company in a research note on Wednesday, February 21st. Royal Bank of Canada decreased their price objective on shares of Teladoc Health from $30.00 to $25.00 and set an outperform rating for the company in a research note on Wednesday, February 21st. DA Davidson cut their target price on shares of Teladoc Health from $22.00 to $18.00 and set a neutral rating for the company in a research report on Wednesday, February 21st. Citigroup cut their price target on shares of Teladoc Health from $21.00 to $19.00 and set a neutral rating on the stock in a report on Wednesday, February 21st. Finally, Needham & Company LLC reiterated a hold rating on shares of Teladoc Health in a report on Friday. Eleven research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, Teladoc Health presently has an average rating of Hold and an average price target of $19.67.

Teladoc Health Stock Performance

NYSE TDOC opened at $13.01 on Friday. Teladoc Health has a 52 week low of $12.65 and a 52 week high of $30.41. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.47 and a current ratio of 3.54. The company has a 50-day moving average price of $15.01 and a two-hundred day moving average price of $17.77.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative return on equity of 10.11% and a negative net margin of 8.90%. The firm had revenue of $646.13 million during the quarter, compared to the consensus estimate of $637.31 million. During the same quarter last year, the company posted ($0.37) EPS. Teladoc Health’s revenue for the quarter was up 2.7% on a year-over-year basis. Sell-side analysts expect that Teladoc Health will post -1.07 EPS for the current fiscal year.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Arnnon Geshuri sold 7,500 shares of the business’s stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $15.06, for a total value of $112,950.00. Following the completion of the transaction, the insider now directly owns 38,470 shares of the company’s stock, valued at $579,358.20. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Teladoc Health news, insider Arnnon Geshuri sold 7,500 shares of the business’s stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $15.06, for a total value of $112,950.00. Following the completion of the transaction, the insider now directly owns 38,470 shares of the company’s stock, valued at $579,358.20. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Laizer Kornwasser sold 7,882 shares of the business’s stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $19.18, for a total transaction of $151,176.76. Following the completion of the transaction, the insider now directly owns 57,223 shares of the company’s stock, valued at $1,097,537.14. The disclosure for this sale can be found here. Insiders have sold a total of 135,441 shares of company stock worth $2,038,251 over the last ninety days. Corporate insiders own 1.63% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors and hedge funds have recently modified their holdings of TDOC. ICA Group Wealth Management LLC acquired a new position in Teladoc Health during the fourth quarter valued at approximately $28,000. Hexagon Capital Partners LLC grew its holdings in Teladoc Health by 204.4% during the fourth quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock valued at $34,000 after purchasing an additional 1,065 shares during the period. RIA Advisory Group LLC acquired a new position in shares of Teladoc Health in the fourth quarter valued at approximately $36,000. GAMMA Investing LLC acquired a new position in shares of Teladoc Health in the fourth quarter valued at approximately $41,000. Finally, Principal Securities Inc. acquired a new position in shares of Teladoc Health in the fourth quarter valued at approximately $45,000. 76.82% of the stock is owned by institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.